To get access to over 10000+ Franchise Business Opportunities.
Network with the growing Business Community to get expert interventions to let you learn to Grow & Expand your Business with Franchising.
Sun Pharmaceutical Industries Ltd.
Sun Pharma is the largest pharmaceutical company in India and one of the world’s leading specialty generic pharmaceutical companies. Ranked as the fourth-largest specialty generic company globally, Sun Pharma has built a strong reputation for providing high-quality, affordable medicines that are trusted by healthcare professionals and patients across more than 100 countries.
Founded in 1983 by Dilip Shanghvi, Sun Pharma began as a small enterprise focused on psychiatric products. Over the decades, through strategic growth, innovation, and global acquisitions, it has evolved into a multinational pharmaceutical powerhouse with a diverse portfolio spanning specialty, generic, and branded medicines.
Leadership in the Indian Pharmaceutical Market
Sun Pharma holds the position of the largest pharmaceutical company in India by market capitalization and revenue. Its dominance in the Indian market is driven by: The company’s leadership is built on its commitment to quality, affordability, and accessibility. Millions of patients in India rely on Sun Pharma’s medicines for the management of acute and chronic conditions.
Global Presence and Specialty Generic Leadership
Beyond India, Sun Pharma has established a strong international footprint. It operates in major markets including: Being the fourth-largest specialty generic pharmaceutical company globally, Sun Pharma focuses on complex generics, specialty medicines, and differentiated products that require advanced manufacturing and regulatory expertise.
In the United States, which is one of the world’s most regulated pharmaceutical markets, Sun Pharma has built a solid presence by meeting stringent standards set by regulatory authorities such as the U.S. Food and Drug Administration. Compliance with such high regulatory standards reflects the company’s commitment to international quality benchmarks.
Commitment to High-Quality Medicines
Quality is the cornerstone of Sun Pharma’s operations. The company maintains world-class manufacturing facilities that comply with Good Manufacturing Practices (GMP) and international regulatory requirements. Sun Pharma’s medicines are trusted by healthcare professionals because of their proven safety, efficacy, and reliability. By maintaining high manufacturing standards, the company ensures that every product delivers consistent therapeutic results.
Diverse Therapeutic Portfolio
Sun Pharma offers a wide and comprehensive product range across multiple therapeutic segments. Its portfolio includes: In addition to generics, the company has a growing specialty portfolio, particularly in dermatology and oncology, addressing complex and chronic conditions.
The company’s focus on specialty medicines allows it to deliver innovative solutions for patients with unmet medical needs.
Research and Innovation
Innovation is a key driver of Sun Pharma’s long-term success. The company invests significantly in research and development (R&D) to enhance existing formulations and develop new therapeutic solutions. By leveraging advanced scientific expertise, Sun Pharma continues to strengthen its pipeline and maintain competitiveness in global markets.
Manufacturing Excellence
Sun Pharma operates multiple manufacturing facilities across India and other countries. These plants are equipped with advanced automation systems and cutting-edge pharmaceutical technology. Its facilities undergo regular inspections by global regulatory authorities, reinforcing its commitment to quality and compliance.
Strategic Acquisitions and Growth
Sun Pharma’s remarkable growth over the years has been supported by strategic acquisitions. One of its most notable acquisitions was Ranbaxy Laboratories, which significantly expanded its global footprint and product base.
Through mergers and acquisitions, Sun Pharma has strengthened its position in key markets and broadened its therapeutic portfolio.
Corporate Responsibility and Ethics
Sun Pharma emphasizes ethical business practices and corporate governance. The company follows transparent policies and adheres to international compliance standards.
In addition to business growth, Sun Pharma is committed to corporate social responsibility (CSR). It supports healthcare initiatives, educational programs, and community development projects aimed at improving societal well-being.
Vision and Mission
Vision:
To be a leading global pharmaceutical company delivering high-quality, innovative, and affordable medicines that improve patient lives worldwide.
Mission:
Trusted by Healthcare Professionals and Patients
One of the most significant achievements of Sun Pharma is the trust it has earned from doctors, pharmacists, hospitals, and patients. Its strong brand equity is built on decades of consistent quality, scientific credibility, and dependable supply chains.
Patients rely on the company’s products for managing both short-term illnesses and long-term chronic conditions.
Sun Pharmaceutical Industries Ltd. stands as a symbol of excellence in the pharmaceutical industry. As the largest pharmaceutical company in India and the fourth-largest specialty generic company globally, Sun Pharma has demonstrated remarkable growth, innovation, and leadership.
Founded by Dilip Shanghvi, the company has evolved into a global healthcare giant committed to delivering high-quality medicines trusted by healthcare professionals and patients worldwide. Through advanced manufacturing, rigorous quality standards, continuous research, and ethical practices, Sun Pharma continues to enhance global healthcare accessibility.
With a strong foundation and forward-looking vision, Sun Pharma remains dedicated to improving lives by making safe, effective, and affordable medicines available to millions across the globe.
Operations Commenced On 1983
Distribution Commenced On 2000
| Types of Channels | Investment (If any) | Margin / Commissions | Area Requirement |
|---|---|---|---|
| Distributor | Rs. 10000 - 50000 | 30% | NIL |
Exclusive territorial rights to a channel partner Yes
Anticipated percentage return on investment 40 %
Likely pay back period of capital for a Channel Partner 1-2 Years
Delhi, Haryana, Himachal Pradesh, Jammu and Kashmir, Punjab, Uttarakhand, Uttar Pradesh
Kerala, Karnataka, Tamil Nadu, Andhra Pradesh, Telangana
Assam, Meghalaya, Mizoram, Tripura, Arunachal Pradesh, Manipur, Nagaland, West Bengal, Sikkim, Odisha
Gujarat, Rajasthan, Maharashtra, Goa
Chhattisgarh, Madhya Pradesh, Bihar, Jharkhand
Andaman and Nicobar, Pondicherry, Chandigarh, Lakshadweep, Daman and Diu, Ladakh
Type of property required for this dealership opportunity Commercial
Floor area requirement 100 - 200 Sq.ft
Do you have a standard dealership agreement? Yes
How long is the dealership term for? Lifetime
Is the term renewable? Yes
Disclaimer: Franchise India is an integrated franchise solution company since 1999, and an absolute authority on franchising and licensing. FIHL (www.franchiseindia.com) and the site sponsors accept no liability for the accuracy of any information contained on this site or on other linked sites. We recommend you take advice from a lawyer, accountant and franchise consultant experienced in franchising before you commit yourself. It is user’s responsibility to satisfy yourself as to the accuracy and reliability of the information supplied. Please read the terms & conditions on Franchise India.
Thanks for showing your interest in Sun Pharma.
Your contact detail has been shared with the company. requested you to create your investor profile and upgrade to directly contact the brand.
Thanks for showing your interest in Sun Pharma.
But you have already applied for Sun Pharma.
Business Opportunities
Browse By Investment Range
Browse By States
Popular Cities
